Flagship Ventures and Merck Research Labs form strategic life sciences collaboration

Cambridge venture capital firm Flagship Ventures said Tuesday that it is partnering with Merck Research Laboratories and its newly formed Merck Research Ventures in a collaboration designed to foster early-stage innovation in life sciences.

Merck & Co. is a large drug company based in New Jersey.

As part of the collaboration, Merck Research Ventures Fund became an investor in Flagship Ventures Fund IV L.P., a $270 million venture capital fund that closed in January, Flagship Ventures said in a press release.

“The collaboration with Flagship underscores Merck’s commitment to fully engage with the entrepreneurial ecosystem at the earliest possible stages and to access breakthrough science for the development of novel therapeutics,’’ Roger Pomerantz, senior vice president of worldwide licensing and knowledge management at Merck, said in a statement.



This discussion has ended. Please join elsewhere on